Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-1392-2020

Drug recall · July 29, 2020

Famotidine Injection recall

Why: TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Famotidine Injection, USP, 20 mg/2mL, 2 mL vial, Rx only, Single Dose Vial, For Intravenous Use Only After Dilution, Distributed by HF Acquisition Co, LLC, Mukilteo, WA 98275, NDC 63323-739-12

Lots / codes

Lot #: 6122639, Exp. Date 08/2021

Quantity
N/A
Company
HF Acquisition Co. LLC, Mukilteo, WA
Distribution
The vials were distributed to one consignee located in CT.
Initiated
June 17, 2020 · Voluntary: Firm initiated
Classified
July 21, 2020
Reported
July 29, 2020
Ended
April 13, 2021
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Famotidine

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.